This inventor holds 18 USPTO granted patents, plus 6 CIPO patents, primarily in Prostaglandin Derivatives. Top assignees: Taisho Pharmaceutical Co., Ltd., Mcw Research Foundation, Inc., Other. Active years: 1983-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Abiko, JP (1983)
- Ageo, JP (1984 - 1986)
- Kounosu, JP (1995 - 1997)
- Tokyo, JP (1996 - 2007)
- Kohnosu, JP (2007)
Company Filing History:
16 out of 314 
1 out of 61 
7 out of 834,601 Years Active: 1983-2007
Areas of Expertise:
Title: Kazuya Kameo: Innovator in Cerebral Vascular Therapy
Introduction
Kazuya Kameo, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 18 patents, Kameo has dedicated his career to innovations that directly impact medical therapy, particularly in the treatment of cerebral vascular diseases.
Latest Patents
Among his latest patents, Kameo has developed a method involving the use of 20-HETE synthesizing enzyme inhibitors as a therapy for cerebral vascular disease. This groundbreaking method aims to treat both humans and non-human animals by inhibiting the enzyme activity to enhance cerebral blood flow. Another significant invention is a benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivatives, which exhibits excellent DPPIV inhibition activity and desirable stability for pharmaceutical preparations. This invention enables the efficient production of the compound in a high-purity, uniform crystal form, which is crucial for effective medical applications.
Career Highlights
Throughout his career, Kameo has been associated with renowned companies, including Taisho Pharmaceutical Co., Ltd., where his research and innovations have contributed to the advancement of pharmaceutical solutions. His work has positioned him as a key figure in the realm of medicinal chemistry, particularly in developing treatments for complex health conditions.
Collaborations
Kameo has collaborated with several notable professionals, including Fumie Sato and Tohru Tanami, who have played essential roles in the research and development phases of his inventions. These collaborations reflect his commitment to harnessing collective expertise to enhance the efficacy of his innovations.
Conclusion
Kazuya Kameo's work continues to make a substantial impact in the medical field, particularly concerning cerebral vascular conditions. His innovative approach and dedication to research pave the way for new therapeutic methods that hold promise for improved patient outcomes. As he continues to expand his patent portfolio, the medical community eagerly anticipates the advancements arising from his ongoing contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile